Skip to Content
Menu
01. Doctor Overview

Doctor Overview

Dr. Gregory Masters is considered a lung cancer specialist in the field, serving patients at the Helen F. Graham Cancer Center & Research Institute after joining the Christiana Care Medical-Dental Staff in 2003. Dr. Masters also serves as an associate professor at the Thomas Jefferson University Medical School in Philadelphia.

To share his knowledge with others, Dr. Masters travels around the United States to talk about lung cancer with various audiences. A noted lecturer and published author on the topic of lung cancer, Dr. Masters is a reviewer for several prominent scientific publications relative to the field of oncology, including Lung CancerThe LancetCancerJournal of Thoracic OncologyClinical Lung CancerJournal of Clinical OncologyAmerican Journal of Clinical Oncology, and the British Journal of Cancer.

02. Fast Facts

Doctor Fast Facts

Main Specialty: Oncology

Other Interests & Specialties: General oncology, hematologic oncology, thoracic cancer, lung cancer, esophageal cancer, gastrointestinal cancer, head and neck cancer and palliative care.

Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology, ACP Fellow, America’s Top Doctors Award, America’s Top Doctors for Cancer Award, Meredith Benjamin Award from Northwestern University Medical School, member of the American College of Physicians, the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the Eastern Cooperative Oncology Group, Cancer and Leukemia Group B, the Radiation Therapy Oncology Group, the American College of Chest Physicians and the Medical Society of Delaware

Education & Experience:

  • Residency for Internal Medicine University of Pennsylvania Health System
  • Fellowship for Hematology/Oncology at University of Chicago
  • Medical Degree from Northwestern University Feinberg School of Medicine
03. Publications

Publications

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible PatientsJournal of Oncology Practice. December 2017;13(12):780-783. doi: 10.1200/JOP.2017.027367

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology. October 2017;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical TrialJama Oncology. March 2016; 2(3):359-67. doi: 10.1001/jamaoncol.2015.3969